KCM
IDXX icon

Kathmere Capital Management’s Idexx Laboratories IDXX Stock Holding History

Kathmere Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+386
New +$217K 0.01% 636
2026
Q1 		– Sell
-320
Closed -$216K – 644
2025
Q4 		$216K Buy
+320
New +$218K 0.01% 506

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kathmere Capital Management's IDXX Position: Q2 2026 in Review

Kathmere Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 386 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #636 among its holdings. This is a return to the name: Kathmere Capital Management previously reported a position in IDXX as recently as Q4 2025.

Kathmere Capital Management first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. The position peaked at $216K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Kathmere Capital Management held 386 shares of Idexx Laboratories worth $203K as of Q2 2026.
  • Idexx Laboratories was a new Kathmere Capital Management position in Q2 2026.
  • Idexx Laboratories made up 0.01% of Kathmere Capital Management's portfolio in Q2 2026, its #636 holding.
  • Kathmere Capital Management first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Kathmere Capital Management's Idexx Laboratories position peaked at $216K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.